Close Menu

Merrimack Pharmaceuticals CEO Robert Mulroy says the traditional approach to cancer — making drugs that go after certain proteins — is "fundamentally flawed," according to the Forbes' Treatments blog's Robert Langreth. Merrimack is now working with Sanofi-Aventis to develop cancer drugs using the principles of systems biology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.